BlackRock, Inc. 13D and 13G filings for Forte Biosciences, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2022-07-08 4:56 pm Sale |
2022-06-30 | 13G | Forte Biosciences, Inc. FBRX |
BlackRock Inc. BLK |
8,562 1.500% |
-24,121 (-73.80%) |
Filing |
| 2022-02-04 4:12 pm Purchase |
2021-12-31 | 13G | Forte Biosciences, Inc. FBRX |
BlackRock Inc. BLK |
32,683 5.500% |
30,705 (+1552.60%) |
Filing |
| 2020-07-10 10:48 am Purchase |
2020-06-30 | 13G | Forte Biosciences, Inc. FBRX |
BlackRock Inc. BLK |
1,978 0.500% |
1,978 (New Position) |
Filing |